Navigation Links
Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services
Date:5/26/2009

AGAWAM, Mass., May 13 /PRNewswire/ -- Microtest Laboratories, a leading single source provider of contract analytical solutions, is adding dissolution testing to its current suite of analytical testing and stability testing services.

"The addition of dissolution testing is the perfect complement to our portfolio of services," said Steven Richter, Ph.D., President and Scientific Founder of Microtest Laboratories (www.microtestlabs.com). "By offering an even more comprehensive array of assays, we're increasing the convenience, efficiency, and value that we deliver as a single, preferred provider of contract laboratory services."

For more information about the new service, visit the Microtest website at: www.microtestlabs.com/analytical-chemistry-testing.

Dissolution is a compendial method used to measure a drug's rate of release from its dosage form. It is a complement to other analytical assays -- potency and related substances (Microtest already offers both) -- that characterize the dosage form.

Dissolution is typically used:

  • To optimize drug delivery rate during development studies
  • For use in routine QC analysis for lot release and to measure lot-to-lot variability
  • For use in stability studies to study the effects of time/temperature/humidity on the dosage form
  • To compare one dosage form to another (different formulations, different processes, analysis of competitor's samples)
  • To estimate release and absorption rates in humans after an in vitro -- in vivo correlation is established

Dissolution is a sample preparation technique. Samples still need to be analyzed separately, usually by Microtest's HPLC or UV Spectroscopy testing. Typical samples are oral dosage forms, although it can also be used on topicals and transdermal systems.

In addition to dissolution testing, Microtest provides a host of analytical assays, including HPLC Assays, GC Analysis, Protein Analysis, FTIR Analysis, and UV/VIS Analysis.

Microtest's analytical testing processes follow guidelines from all major standards authorities, including the United States Pharmacopeia (USP), the Japanese and European Pharmacopoeias, the U.S. Food and Drug Administration (FDA), the International Organization for Standardization (ISO), and the Association for Advancement of Medical Instrumentation (AAMI).

For more information, visit the Microtest website at www.microtestlabs.com/analytical-chemistry-testing or call 1-800-631-1680.

Or, visit Microtest at the 2009 Bio International Convention in Atlanta, May 18th-21st, in Booth 2803 in the Massachusetts Pavilion.

About Microtest

Microtest is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, biotechnology industries. Based in Agawam, Massachusetts, USA, the company's expertise and flexible processes enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680.

Available Topic Expert: For information on the listed expert, click appropriate link.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=42622


'/>"/>
SOURCE Microtest Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Queens scientists discover eco-friendly wood dissolution
2. Comprehensive cardiogenetic testing for families of sudden unexplained death victims can save lives
3. Genetic testing for breast or ovarian cancer risk may be greatly underutilized
4. Countries unite to reduce animal use in product toxicity testing worldwide
5. Cystic fibrosis testing -- next steps
6. Blood testing, mosquito style
7. Fetal alcohol syndrome testing expands
8. New reference material can improve testing of multivitamin tablets
9. Consumers desire more genetic testing, but not designer babies
10. Genetic testing not cost-effective in guiding initial dosing of common blood thinner
11. DNA testing may unlock secrets of medieval manuscripts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/7/2017)... , March 7, 2017   HireVue , the ... global companies identify the best talent, faster, today announced ... Sales Officer (CSO) and Diana Kucer as ... out a seasoned executive team poised to drive continued growth ... on a year of record bookings in 2017. ...
(Date:3/2/2017)... 2, 2017 Australian stem cell and regenerative ... has signed an agreement with the Monash Lung Biology ... Discovery Institute and Department of Pharmacology at Monash University, ... preclinical study to support the use of Cymerus™ mesenchymal ... Asthma is a chronic, long term lung ...
(Date:2/27/2017)... WASHINGTON , Feb. 27, 2017   Strategic ... fund, today announced it has led a $3.5 million investment ... collaboration platform. Strategic Cyber Ventures is DC based and ... and Hank Thomas . Ron Gula , ... Tech Ventures, also participated in this series A round ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... ... March 28, 2017 , ... Benchworks ... 22 in Philadelphia. The event was offered by the Chamber of Commerce for ... featured breakout groups and interaction with speakers who are leaders in their industries. ...
(Date:3/28/2017)... , Belgium , March 28, 2017 ... VolitionRx Limited (NYSE MKT: VNRX), today announced the engagement of ... DVD Associates, LLC, as a strategic consultant. Dr. Vollmer ... identifying and securing non-dilutive funding in the State ... United States . Dr. Vollmer Dahlke has ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... initial release of LabKey’s newest software solution, LabKey Biologics . Built in ... pharma and biotech organizations, LabKey Biologics provides drug research teams tools for biological ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... development of a new orally administered treatment for Alzheimer’s disease (AD), today announced ... Didsbury states, “As we seek to uniquely treat the metabolic dysfunctions inherent in ...
Breaking Biology Technology: